S&P 500   3,776.79 (-0.37%)
DOW   30,241.48 (-0.25%)
QQQ   281.10 (-0.37%)
AAPL   145.88 (-0.15%)
MSFT   248.38 (-0.20%)
META   137.91 (-1.69%)
GOOGL   100.78 (-0.85%)
AMZN   120.44 (-0.54%)
TSLA   238.96 (-4.20%)
NVDA   131.29 (-0.29%)
NIO   15.91 (-4.90%)
BABA   84.13 (+0.02%)
AMD   67.64 (-0.38%)
T   15.91 (-1.12%)
MU   54.69 (+1.35%)
CGC   3.02 (-3.82%)
F   12.46 (+0.81%)
GE   67.59 (+0.07%)
DIS   100.11 (-1.31%)
AMC   7.39 (-5.62%)
PYPL   93.83 (+1.12%)
PFE   44.04 (-0.94%)
NFLX   233.71 (-2.92%)
S&P 500   3,776.79 (-0.37%)
DOW   30,241.48 (-0.25%)
QQQ   281.10 (-0.37%)
AAPL   145.88 (-0.15%)
MSFT   248.38 (-0.20%)
META   137.91 (-1.69%)
GOOGL   100.78 (-0.85%)
AMZN   120.44 (-0.54%)
TSLA   238.96 (-4.20%)
NVDA   131.29 (-0.29%)
NIO   15.91 (-4.90%)
BABA   84.13 (+0.02%)
AMD   67.64 (-0.38%)
T   15.91 (-1.12%)
MU   54.69 (+1.35%)
CGC   3.02 (-3.82%)
F   12.46 (+0.81%)
GE   67.59 (+0.07%)
DIS   100.11 (-1.31%)
AMC   7.39 (-5.62%)
PYPL   93.83 (+1.12%)
PFE   44.04 (-0.94%)
NFLX   233.71 (-2.92%)
S&P 500   3,776.79 (-0.37%)
DOW   30,241.48 (-0.25%)
QQQ   281.10 (-0.37%)
AAPL   145.88 (-0.15%)
MSFT   248.38 (-0.20%)
META   137.91 (-1.69%)
GOOGL   100.78 (-0.85%)
AMZN   120.44 (-0.54%)
TSLA   238.96 (-4.20%)
NVDA   131.29 (-0.29%)
NIO   15.91 (-4.90%)
BABA   84.13 (+0.02%)
AMD   67.64 (-0.38%)
T   15.91 (-1.12%)
MU   54.69 (+1.35%)
CGC   3.02 (-3.82%)
F   12.46 (+0.81%)
GE   67.59 (+0.07%)
DIS   100.11 (-1.31%)
AMC   7.39 (-5.62%)
PYPL   93.83 (+1.12%)
PFE   44.04 (-0.94%)
NFLX   233.71 (-2.92%)
S&P 500   3,776.79 (-0.37%)
DOW   30,241.48 (-0.25%)
QQQ   281.10 (-0.37%)
AAPL   145.88 (-0.15%)
MSFT   248.38 (-0.20%)
META   137.91 (-1.69%)
GOOGL   100.78 (-0.85%)
AMZN   120.44 (-0.54%)
TSLA   238.96 (-4.20%)
NVDA   131.29 (-0.29%)
NIO   15.91 (-4.90%)
BABA   84.13 (+0.02%)
AMD   67.64 (-0.38%)
T   15.91 (-1.12%)
MU   54.69 (+1.35%)
CGC   3.02 (-3.82%)
F   12.46 (+0.81%)
GE   67.59 (+0.07%)
DIS   100.11 (-1.31%)
AMC   7.39 (-5.62%)
PYPL   93.83 (+1.12%)
PFE   44.04 (-0.94%)
NFLX   233.71 (-2.92%)

Apollo Medical - AMEH Stock Forecast, Price & News

$39.65
-1.26 (-3.08%)
(As of 10/5/2022 01:39 PM ET)
Add
Compare
Today's Range
$39.05
$40.19
50-Day Range
$39.00
$56.87
52-Week Range
$29.52
$133.23
Volume
2,628 shs
Average Volume
294,388 shs
Market Capitalization
$2.24 billion
P/E Ratio
24.78
Dividend Yield
N/A
Price Target
$57.00

Apollo Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
44.5% Upside
$57.00 Price Target
Short Interest
Bearish
11.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.63
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
15.69%
From $1.02 to $1.18 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.50 out of 5 stars

Medical Sector

157th out of 1,087 stocks

Management Consulting Services Industry

6th out of 19 stocks

AMEH stock logo

About Apollo Medical (NASDAQ:AMEH) Stock

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

AMEH Stock News Headlines

Apollo Medical Holdings Becomes Oversold (AMEH)
Apollo Medical Holdings, Inc. Reports Second Quarter 2022 Results
Apollo Medical Hlgs: Q4 Earnings Insights
See More Headlines
Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

AMEH Company Calendar

Last Earnings
11/04/2021
Today
10/05/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AMEH
Employees
1,133
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$57.00
High Stock Price Forecast
$57.00
Low Stock Price Forecast
$57.00
Forecasted Upside/Downside
+43.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$73.86 million
Pretax Margin
0.73%

Debt

Sales & Book Value

Annual Sales
$773.91 million
Cash Flow
$1.68 per share
Book Value
$8.29 per share

Miscellaneous

Free Float
49,962,000
Market Cap
$2.24 billion
Optionable
Not Optionable
Beta
0.79

Key Executives

  • Dr. Kenneth T. Sim M.D. (Age 68)
    Exec. Chairman
    Comp: $1.09M
  • Dr. Thomas S. Lam M.D. (Age 73)
    M.P.H., Pres, Co-CEO & Director
    Comp: $1.08M
  • Mr. Brandon SimMr. Brandon Sim (Age 28)
    Co-Chief Exec. Officer
    Comp: $1.04M
  • Dr. WaiChow Young M.D. (Age 75)
    Chief Admin. Officer
    Comp: $453.73k
  • Mr. Chan Basho
    Chief Strategy Officer & Interim CFO
  • Dr. Jeremy R. Jackson M.D.
    Chief Quality Officer
  • Mr. Neil Ahuja
    Pres of Provider Solutions
  • Yubin Park
    Chief Analytics Officer













AMEH Stock - Frequently Asked Questions

Should I buy or sell Apollo Medical stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AMEH shares.
View AMEH analyst ratings
or view top-rated stocks.

What is Apollo Medical's stock price forecast for 2022?

3 equities research analysts have issued 1-year target prices for Apollo Medical's stock. Their AMEH share price forecasts range from $57.00 to $57.00. On average, they predict the company's share price to reach $57.00 in the next twelve months. This suggests a possible upside of 39.3% from the stock's current price.
View analysts price targets for AMEH
or view top-rated stocks among Wall Street analysts.

How have AMEH shares performed in 2022?

Apollo Medical's stock was trading at $73.48 at the start of the year. Since then, AMEH stock has decreased by 44.3% and is now trading at $40.91.
View the best growth stocks for 2022 here
.

When is Apollo Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our AMEH earnings forecast
.

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) released its earnings results on Thursday, November, 4th. The company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.35. The company had revenue of $227.12 million for the quarter. Apollo Medical had a trailing twelve-month return on equity of 15.80% and a net margin of 7.72%. During the same period in the previous year, the business posted $0.45 earnings per share.

What guidance has Apollo Medical issued on next quarter's earnings?

Apollo Medical issued an update on its FY 2022 earnings guidance on Thursday, September, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.05 billion-$1.08 billion, compared to the consensus revenue estimate of $1.06 billion.

What is Thomas Lam's approval rating as Apollo Medical's CEO?

15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM).

What is Apollo Medical's stock symbol?

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

How do I buy shares of Apollo Medical?

Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apollo Medical's stock price today?

One share of AMEH stock can currently be purchased for approximately $40.91.

How much money does Apollo Medical make?

Apollo Medical (NASDAQ:AMEH) has a market capitalization of $2.31 billion and generates $773.91 million in revenue each year. The company earns $73.86 million in net income (profit) each year or $1.60 on an earnings per share basis.

How many employees does Apollo Medical have?

The company employs 1,133 workers across the globe.

How can I contact Apollo Medical?

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for the company is www.apollomed.net. The company can be reached via phone at (626) 943-6491, via email at investors@apollomed.net, or via fax at 818-839-5190.

This page (NASDAQ:AMEH) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.